DSM-5 mixed specifier for manic episodes: Evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data

This publication has 15 references indexed in Scilit:

• Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: Results from post hoc analyses
  Journal of Affective Disorders, 2013
• Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder
  Annals of the New York Academy of Sciences, 2011
• Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis
  The Lancet, 2011
• Asenapine in the treatment of acute mania in bipolar I disorder: A randomized, double-blind, placebo-controlled trial
  Journal of Affective Disorders, 2010
• A 3‐week, randomized, placebo‐controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states
  Bipolar Disorders, 2009
• Understanding the Complexity of Bipolar Mixed Episodes
  The Journal of Clinical Psychiatry, 2008
• Mixed Hypomania in 908 Patients With Bipolar Disorder Evaluated Prospectively in the Stanley Foundation Bipolar Treatment Network
  Archives of General Psychiatry, 2005
• Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania
  American Journal of Psychiatry, 1992
• The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
  Schizophrenia Bulletin, 1987
• Depressive symptoms in acute schizophrenia
  Progress in Neuro-Psychopharmacology, 1979